For individuals, friends and families who are looking to connect during life's challenging times. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.
Sponsored Links
Main Menu
Community
Treatment
Understand
- Where to Start
- What is Lymphoma?
- The Lymphatic System
- Lymphoma Symptoms
- Lymphoma Causes
- Lymphoma Prognosis
- Refractory/Relapsed Lymphoma
Non-Hodgkin's Lymphoma
Hodgkin's Disease
Surviving Lymphoma
Lymphoma and Pets
More
Drug Shows Some Promise for PTCL Sufferers
-
Call (877) 399-6937 or click here to learn more about Cancer Treatment options.
Peripheral T-cell lymphoma (PTCL) attacks only about ten percent of people diagnosed with non-Hodgkin's lymphoma every year but it’s a very deadly form of lymphoma and one of the most difficult to treat. Furthermore, there are currently no FDA-approved treatments for PTCL.
A recent clinical trial carried out by Allos Therapeutics for the experimental drug pralatrexate showed that of the 115 PTCL patients, 27% responded to the drug while 11% reached full remission. Patients responded to the drug for an average of 9.4 months, substantially longer than anyone expected.
The good results surprised Allos. They intend to seek regulatory approval of pralatrexate, also known as PDX, later this year. The FDA has granted the drug orphan status, and Allos is testing it against other forms of cancer.
Pralatrexate works by disguising itself as a folic acid which a cancerous tumor readily absorbs. Once inside, the drug attacks the tumor.
A recent clinical trial carried out by Allos Therapeutics for the experimental drug pralatrexate showed that of the 115 PTCL patients, 27% responded to the drug while 11% reached full remission. Patients responded to the drug for an average of 9.4 months, substantially longer than anyone expected.
The good results surprised Allos. They intend to seek regulatory approval of pralatrexate, also known as PDX, later this year. The FDA has granted the drug orphan status, and Allos is testing it against other forms of cancer.
Pralatrexate works by disguising itself as a folic acid which a cancerous tumor readily absorbs. Once inside, the drug attacks the tumor.
-
Call (877) 399-6937 or click here to learn more about Cancer Treatment options.
Support Groups
Find a Treatment Facility Near You
Click on a state below to find Lymphoma treatment options that could be right for you.
Select a State Below
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.
Sponsored Links
LymphomaInfo Social
SupportGroups.com
SupportGroups.com provides a support network for those dealing with cancer and other life's challenges. Click on the following links to get the support in a confidential, caring environment.
Follow LymphomaInfo.net on:
Facebook:
Twitter: